Home News Page 65

News

Lonza to Expand Antibody Drug Conjugate (ADC) Manufacturing Capacity to Meet Growing Customer Demand

Lonza today announced plans to invest CHF 14 million to expand Antibody Drug Conjugate (ADC) manufacturing capacity in Visp,...

Celgene wraps $500M deal to partner with Sutro on next-gen ADCs Read more: Celgene...

Antibody-drug conjugates are hot. Next-gen ADCs are even hotter. So Celgene has turned to the upstart ADC developers at...

Intellect Neurosciences Awards Future Development and Manufacture of the Antibody-drug Conjugate CONJUMAB-A to Lonza.

Lonza announced today that Intellect Neurosciences, Inc. awarded the future development and manufacture of the antibody drug conjugate CONJUMAB-A...

Researchers Develop Antibody-drug Conjugate Technology for Hematologic Disorders

Antibody-drug conjugates (ADCs) combine cytotoxic chemotherapy and antibody specificity. There are 4 components of ADC technology: the cancer, or...

Genmab and Lonza Enter in Development and Manufacturing Agreement for HuMax-TF™ – A Novel...

Lonza announces a new development and manufacturing agreement with Genmab A/S. This agreement secures a development and cGMP manufacturing...

FEATURED RESOURCES